---
nav_exclude: true
title: "Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023"
source_url: "https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=741534"
source_layer: us_cdc_mmwr
category: surveillance_summary
date: 2024-01-11
confidence: 中
mmwr_volume: ""
mmwr_issue: ""
seo:
  json_ld:
    - "@context": "https://schema.org"
      "@type": "WebPage"
      "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#webpage"
      name: "Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023"
      url: "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i"
      description: "This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis."
      isPartOf:
        "@id": "https://epialert.weiqi.kids#website"
      about:
        "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#article"
      breadcrumb:
        "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#breadcrumb"
      inLanguage: zh-TW
      potentialAction:
        - "@type": ReadAction
          target:
            - "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i"
    - "@context": "https://schema.org"
      "@type": Article
      "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#article"
      headline: "Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023"
      description: "This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis."
      datePublished: "2024-01-11"
      dateModified: "2024-01-11"
      author:
        "@id": "https://epialert.weiqi.kids/about#person"
      publisher:
        "@id": "https://epialert.weiqi.kids#organization"
      mainEntityOfPage:
        "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#webpage"
      url: "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i"
      inLanguage: zh-TW
      isPartOf:
        "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#webpage"
    - "@context": "https://schema.org"
      "@type": Person
      "@id": "https://epialert.weiqi.kids/about#person"
      name: EpiAlert AI 編輯
      description: "EpiAlert 疫情快訊的 AI 編輯系統，負責收集、分析並報導全球疫情資訊"
      url: "https://epialert.weiqi.kids/about"
    - "@context": "https://schema.org"
      "@type": Organization
      "@id": "https://epialert.weiqi.kids#organization"
      name: EpiAlert 疫情快訊
      url: "https://epialert.weiqi.kids"
      logo:
        "@type": ImageObject
        url: "https://epialert.weiqi.kids/assets/images/logo.png"
    - "@context": "https://schema.org"
      "@type": BreadcrumbList
      "@id": "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary/2026/2026-02-05-effectiveness-of-bivalent-mrna-covid-19-vaccines-i#breadcrumb"
      itemListElement:
        - "@type": ListItem
          position: 1
          name: 首頁
          item: "https://epialert.weiqi.kids"
        - "@type": ListItem
          position: 2
          name: CDC MMWR
          item: "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr"
        - "@type": ListItem
          position: 3
          name: 監測摘要
          item: "https://epialert.weiqi.kids/Extractor/us_cdc_mmwr/surveillance_summary"
        - "@type": ListItem
          position: 4
          name: "Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023"
  ymyl:
    is_ymyl: true
    category: health
    disclaimer: "本內容僅供參考，不構成醫療建議。如需專業醫療諮詢，請聯繫合格的醫療保健提供者。"
  speakable:
    selectors:
      - .article-summary
      - .speakable-content
      - .key-takeaway
      - .key-answer
      - .expert-quote
      - .actionable-steps li
      - .faq-answer-content
---

## 摘要

This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis.

## 詳細內容

This report describes how bivalent COVID-19 vaccines were nearly 50% effective in preventing COVID-19-related thromboembolic events among adults aged 65 and older and those on dialysis.

## 關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---
*萃取時間: 2026-02-05T15:10:19Z*
*資料來源: CDC MMWR*
